From 2024 to 2028, the forecasted sold production of medicaments containing corticosteroid hormones in Germany shows a consistent annual increase. The year-on-year growth rates depict a positive trend, with gradual increments, reflecting steady demand growth.
The compound annual growth rate (CAGR) for this period is indicative of a consistent average increase per year. Compared to 2023, where the actual value was lower, this forecast suggests a progressive market expansion.
Future trends to watch for:
- Increased demand due to aging populations and rising chronic illness cases.
- Regulatory changes impacting production and pricing strategies.
- Technological advancements in pharmaceutical production.
- Potential market shifts due to emerging healthcare policies.
